Antiviral quinolinone compounds
    5.
    发明授权
    Antiviral quinolinone compounds 失效
    抗病毒喹啉酮化合物

    公开(公告)号:US5179107A

    公开(公告)日:1993-01-12

    申请号:US811890

    申请日:1991-12-19

    摘要: Compounds useful as antiviral agents against DNA containing viruses, such as herpes group viruses, are disclosed. The compounds are selected from the group consisting of: ##STR1## and their pharmaceutically acceptable salts and solvates. Pharmaceutical compositions containing compounds represented by Formula 1.0 are disclosed. Also disclosed are methods of treating a viral infection using compounds represented by Formula 1.0.A process for making compounds of Formula 1.0 from the appropriate 3-oximino-quinolin-2,4(1H)-dione (Formula 2.5) is also disclosed. The process comprises reductively hydrolyzing an appropriate 3-oximino-quinolin-2,4(1H)-dione (Formula 2.5) in a mixture with a hydrogenation catalyst and an acidic solvent mixture.

    摘要翻译: 公开了用作抗病毒药物的化合物,其可用于含有病毒的DNA,如疱疹病毒。 化合物选自:式1.0(1.0)及其药学上可接受的盐和溶剂合物。 公开了含有由式1.0表示的化合物的药物组合物。 还公开了使用由式1.0表示的化合物治疗病毒感染的方法。 还公开了从适当的3-肟基 - 喹啉-2,4(1H) - 二酮制备式1.0化合物的方法(式2.5)。 该方法包括在与氢化催化剂和酸性溶剂混合物的混合物中还原性水解合适的3-肟基 - 喹啉-2,4(1H) - 二酮(式2.5)。

    4-substituted pyrazoloquinoline derivatives
    8.
    发明授权
    4-substituted pyrazoloquinoline derivatives 失效
    4-取代的吡唑并喹啉衍生物

    公开(公告)号:US5786480A

    公开(公告)日:1998-07-28

    申请号:US691768

    申请日:1996-08-02

    IPC分类号: C07D471/04

    CPC分类号: C07D471/04

    摘要: Compounds of the formula ##STR1## wherein R.sub.1, R.sub.3, R.sub.4, R.sub.11, and c are as set forth herein are described. These compounds are useful as agents for the treatment of mammals infected with herpes group virus. Certain of these compounds are useful as antitumor agents.

    摘要翻译: 其中R 1,R 3,R 4,R 11和c如本文所述的式Ⅺ的化合物被描述。 这些化合物可用作治疗感染疱疹病毒的哺乳动物的药剂。 这些化合物中的某些可用作抗肿瘤剂。